Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers

被引:38
|
作者
Ruan, Miao [1 ,2 ]
Tian, Tian [1 ,2 ]
Rao, Jia [1 ,2 ]
Xu, Xiaoli [1 ,2 ]
Yu, Baohua [1 ,2 ]
Yang, Wentao [1 ,2 ]
Shui, Ruohong [1 ,2 ]
机构
[1] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
关键词
Tumor-infiltrating lymphocytes; Breast cancer; Triple-negative; Pathological complete response; Predictive factor; PROGNOSTIC VALUE; CHEMOTHERAPY; SURVIVAL; RECOMMENDATIONS; THERAPY; TILS;
D O I
10.1186/s13000-018-0743-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Triple-negative breast cancers (TNBCs) are a group of heterogeneous diseases with various morphology, prognosis, and treatment response. Therefore, it is important to identify valuable biomarkers to predict the therapeutic response and prognosis for TNBCs. Tumor-infiltrating lymphocytes (TILs) may have predictive value to pathological complete response (pCR) in neoadjuvant treated TNBCs. However, absence of standardized methodologies for TILs measurement has limited its evaluation and application in practice. In 2014, the International TILs Working Group formulated the recommendations of pathologic evaluation for TILs in breast cancers. Methods: To evaluate the predictive value of TILs scored by methods recommended by International TILs Working Group 2014, we performed a retrospective study of TILs in 166 core needle biopsy specimens of primary invasive TNBCs with neoadjuvant chemotherapy (NAC) in a Chinese population. Intratumoral TILs (TILs) and stromal TILs (sTILs) were scored respectively. The associations between TILs and pCR were analyzed. Results: Both sTILs (p = 0.0001) and iTILs (P = 0.001) were associated with pCR in univariate logistic regression analysis. Multivariate logistic regression analysis indicated that both sTILs (P = 0.006) and TILs (P= 0.04) were independent predictors for pCR. Receiver operating characteristics (ROC) curve analysis was used to identify the optimal thresholds of TILs. TNBCs with more than 20% sTILs (P = 0.001) or with more than 10% iTILs (P = 0.003) were associated with higher pCR rates in univariate analysis. Multivariate analysis showed that a 20% threshold of sTILs (P= 0.005) was an independent predictive factor for pCR. Conclusions: Our study indicated that Its scored by recommendations of International Its Working Group 2014 in pre-NAC core needle biopsy specimens was significantly correlated with pCR in TNBCs, higher TILs scores predicting higher pCR rate. Both sTILs and iTILs were independent predictors for pCR in TNBCs. A 20% threshold for sILs may be feasible to predict pCR to NAC in TNBCs.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Tumor infiltrating lymphocytes profile and response in neoadjuvant chemotherapy-treated triple-negative breast carcinoma patients
    Ray, Debadrita
    Das Gupta, Senjuti
    De, Arka
    Jain, Parul
    Bhattacharya, Nirmal Kumar
    Biswas, Pranab Kumar
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1782 - +
  • [22] Predictive factors of pathological complete response to neoadjuvant therapy in triple-negative breast carcinoma
    Costa, J.
    Coimbra, N.
    Lopes, P.
    Antunes, L.
    Souto Moura, M.
    Leal, C.
    VIRCHOWS ARCHIV, 2020, 477 : S44 - S44
  • [23] Predictive and prognostic value of tumor-infiltrating lymphocytes in breast cancer treated with neoadjuvant chemotherapy.
    Matsumoto, Akiko
    Jinno, Hiromitsu
    Hiraiwa, Kunihiko
    Nakamura, Tetsuya
    Saito, Junichi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [24] The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
    Ibrahim, Ezzeldin M.
    Al-Foheidi, Meteb E.
    Al-Mansour, Mubarak M.
    Kazkaz, Ghieth A.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 148 (03) : 467 - 476
  • [25] Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
    Kuroda, Hajime
    Jamiyan, Tsengelmaa
    Yamaguchi, Rin
    Kakumoto, Akinari
    Abe, Akihito
    Harada, Oi
    Enkhbat, Bayarmaa
    Masunaga, Atsuko
    BREAST CANCER, 2021, 28 (04) : 904 - 914
  • [26] Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
    Hajime Kuroda
    Tsengelmaa Jamiyan
    Rin Yamaguchi
    Akinari Kakumoto
    Akihito Abe
    Oi Harada
    Bayarmaa Enkhbat
    Atsuko Masunaga
    Breast Cancer, 2021, 28 : 904 - 914
  • [27] The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
    Ezzeldin M. Ibrahim
    Meteb E. Al-Foheidi
    Mubarak M. Al-Mansour
    Ghieth A. Kazkaz
    Breast Cancer Research and Treatment, 2014, 148 : 467 - 476
  • [28] Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer-Reply
    Leon-Ferre, Roberto A.
    Salgado, Roberto
    Jonas, Sarah Flora
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (04): : 337 - 338
  • [29] Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients
    Altundag, Kadri
    BREAST CANCER, 2025, 32 (02) : 456 - 456
  • [30] Immunotyping of tumor-infiltrating lymphocytes in triple-negative breast cancer and genetic characterization
    Sofia Gomez-Macias, Gabriela
    Molinar-Flores, Guillermo
    Lopez-Garcia, Carlos A.
    Santuario-Facio, Sandra
    Decanini-Arcaute, Horacio
    Valero-Elizondo, Javier
    Trevino-Alvarado, Victor
    Ortiz-Lopez, Rocio
    Dono, Antonio
    Esteban-Zubero, Eduardo
    Alatorre-Jimenez, Moises A.
    Villarreal Garza, Cynthia
    Pena-Curiel, Omar
    Cardona-Huerta, Servando
    ONCOLOGY LETTERS, 2020, 20 (05)